Steinar Lundgren

6.2k total citations
104 papers, 4.1k citations indexed

About

Steinar Lundgren is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, Steinar Lundgren has authored 104 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 38 papers in Radiology, Nuclear Medicine and Imaging and 30 papers in Genetics. Recurrent topics in Steinar Lundgren's work include Estrogen and related hormone effects (27 papers), MRI in cancer diagnosis (20 papers) and Breast Cancer Treatment Studies (17 papers). Steinar Lundgren is often cited by papers focused on Estrogen and related hormone effects (27 papers), MRI in cancer diagnosis (20 papers) and Breast Cancer Treatment Studies (17 papers). Steinar Lundgren collaborates with scholars based in Norway, United States and United Kingdom. Steinar Lundgren's co-authors include Tone F. Bathen, Ingrid S. Gribbestad, Beathe Sitter, Hans E. Fjøsne, Per Eystein Lønning, Stener Kvinnsland, Guro F. Giskeødegård, Ernst A. Lien, Jostein Halgunset and Kjell Arne Kvistad and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Steinar Lundgren

100 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steinar Lundgren Norway 37 1.4k 1.3k 1.2k 1.1k 1.0k 104 4.1k
Takanori Ishida Japan 44 2.0k 1.5× 1.8k 1.4× 2.3k 1.8× 1.1k 1.0× 746 0.7× 215 5.7k
Harold A. Harvey United States 43 1.3k 0.9× 864 0.7× 2.3k 1.8× 1.6k 1.6× 484 0.5× 130 5.0k
I E Smith United Kingdom 23 777 0.6× 1.5k 1.2× 1.8k 1.5× 1.1k 1.1× 410 0.4× 59 3.5k
Stener Kvinnsland Norway 30 734 0.5× 635 0.5× 1.2k 1.0× 1.3k 1.2× 290 0.3× 106 3.0k
Stephen F. Madden Ireland 47 4.8k 3.4× 1.4k 1.1× 2.2k 1.8× 688 0.6× 238 0.2× 164 8.1k
T.J. Powles United Kingdom 34 777 0.6× 1.2k 0.9× 1.9k 1.5× 1.1k 1.1× 671 0.6× 73 3.7k
Bryan P. Schneider United States 37 1.7k 1.2× 1.1k 0.9× 3.3k 2.7× 327 0.3× 819 0.8× 165 6.3k
C. Kent Osborne United States 33 2.2k 1.5× 2.1k 1.6× 2.9k 2.4× 1.8k 1.7× 565 0.5× 82 5.6k
Vessela N. Kristensen Norway 37 3.2k 2.3× 2.3k 1.8× 1.4k 1.1× 806 0.8× 232 0.2× 132 5.1k
Epie Boven Netherlands 45 3.0k 2.1× 1.1k 0.8× 3.3k 2.6× 283 0.3× 1.6k 1.5× 190 7.5k

Countries citing papers authored by Steinar Lundgren

Since Specialization
Citations

This map shows the geographic impact of Steinar Lundgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steinar Lundgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steinar Lundgren more than expected).

Fields of papers citing papers by Steinar Lundgren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steinar Lundgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steinar Lundgren. The network helps show where Steinar Lundgren may publish in the future.

Co-authorship network of co-authors of Steinar Lundgren

This figure shows the co-authorship network connecting the top 25 collaborators of Steinar Lundgren. A scholar is included among the top collaborators of Steinar Lundgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steinar Lundgren. Steinar Lundgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nikolaienko, Oleksii, Hans Petter Eikesdal, Bjørnar Gilje, et al.. (2023). Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development. Genome Medicine. 15(1). 104–104. 13 indexed citations
2.
Lien, Tonje G., Xavier Tekpli, Laxmi Silwal‐Pandit, et al.. (2020). Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER‐positive breast cancer. International Journal of Cancer. 147(9). 2515–2525. 14 indexed citations
3.
Sulheim, Einar, Jana Kim, Annemieke van Wamel, et al.. (2018). Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models. Journal of Controlled Release. 279. 292–305. 36 indexed citations
4.
Cao, Maria Dung, Guro F. Giskeødegård, Tone F. Bathen, et al.. (2012). Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer. 12(1). 39–39. 71 indexed citations
5.
Reidunsdatter, Randi Johansen, Toril Rannestad, Jomar Frengen, Gunilla Frykholm, & Steinar Lundgren. (2011). Early effects of contemporary breast radiation on health-related quality of life – Predictors of radiotherapy-related fatigue. Acta Oncologica. 50(8). 1175–1182. 26 indexed citations
6.
Lundgren, Steinar, et al.. (2011). Monitoring neoadjuvant chemotherapy in breast cancer patients: Improved MR assessment at 3 T?. Journal of Magnetic Resonance Imaging. 34(3). 547–556. 14 indexed citations
7.
Kodama, Yosuke, Natale Rolim, Marius Widerøe, et al.. (2010). A rat model of intravesical delivery of small interfering RNA for studying urinary carcinoma. World Journal of Urology. 28(4). 479–485. 7 indexed citations
8.
Røe, Oluf Dimitri, Jenette Creaney, Steinar Lundgren, et al.. (2008). Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case–control study. Lung Cancer. 61(2). 235–243. 45 indexed citations
9.
Sjøbakk, Torill Eidhammer, Tone F. Bathen, Ursula Sonnewald, et al.. (2007). Characterization of brain metastases using high‐resolution magic angle spinning MRS. NMR in Biomedicine. 21(2). 175–185. 28 indexed citations
10.
Sitter, Beathe, Steinar Lundgren, Tone F. Bathen, et al.. (2005). Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR in Biomedicine. 19(1). 30–40. 179 indexed citations
11.
Lundgren, Steinar, et al.. (2002). Effects of growth factors on growth and radiation sensitivity of the human breast cancer cell line T-47D. Oncology Reports. 9(2). 397–403. 6 indexed citations
12.
Lundgren, Steinar, Stig Jørgensen, & Rolf Kåresen. (2001). Brystkreftkirurgi i Norge 1990 – 95 belyst med data fra SINTEF Unimed. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
13.
Kvistad, Kjell Arne, et al.. (2000). Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. European Radiology. 10(9). 1464–1471. 146 indexed citations
14.
Kvistad, Kjell Arne, et al.. (2000). Breast Lesions: Evaluation with Dynamic Contrast-enhanced T1-weighted MR Imaging and with T2*-weighted First-Pass Perfusion MR Imaging. Radiology. 216(2). 545–553. 65 indexed citations
15.
Diamandis, Eleftherios P., Svein Inge Helle, He Yu, et al.. (1999). Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma. Cancer. 85(4). 891–898. 22 indexed citations
16.
Jonat, W., Anthony Howell, Carl Blomqvist, et al.. (1996). A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *. European Journal of Cancer. 32(3). 404–412. 207 indexed citations
17.
Lundgren, Steinar, et al.. (1990). Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer-I. general findings. Journal of Steroid Biochemistry. 36(1-2). 99–104. 16 indexed citations
18.
19.
Lundgren, Steinar, et al.. (1989). Oral High-Dose Progestins as Treatment for Advanced Breast Cancer. Acta Oncologica. 28(6). 811–816. 11 indexed citations
20.
Lundgren, Steinar, et al.. (1988). Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancer. Journal of Steroid Biochemistry. 31(4). 437–441. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takanori Ishida Breakdown of academic impact, for papers by Harold A. Harvey Breakdown of academic impact, for papers by I E Smith Breakdown of academic impact, for papers by Stener Kvinnsland Breakdown of academic impact, for papers by Stephen F. Madden Breakdown of academic impact, for papers by T.J. Powles Breakdown of academic impact, for papers by Bryan P. Schneider Breakdown of academic impact, for papers by C. Kent Osborne Breakdown of academic impact, for papers by Vessela N. Kristensen Breakdown of academic impact, for papers by Epie Boven
Rankless by CCL
2026